Baseline Characteristics and mNAPSI Change from Baseline Scores Through Month 12 for Patients with Moderate-to-Severe Plaque Psoriasis and Concomitant Nail Psoriasis Treated with Biologics from PSoHO-Reference-Cited by-同舟云学术

Baseline Characteristics and mNAPSI Change from Baseline Scores Through Month 12 for Patients with Moderate-to-Severe Plaque Psoriasis and Concomitant Nail Psoriasis Treated with Biologics from PSoHO

Published:2024-04-22 Issue:5 Volume:14 Page:1327-1335
ISSN:2193-8210
Container-title:Dermatology and Therapy
language:en
Short-container-title:Dermatol Ther (Heidelb)

Author:

Riedl Elisabeth^ORCID,Pinter Andreas,Zaheri Shirin,Costanzo Antonio,Brnabic Alan,Konicek Bruce,McKenzie Robert,Lampropoulou Anastasia,Rayes Mohamed El,Haustrup Natalie,Schuster Christopher

Funder

Eli Lilly and Company

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s13555-024-01150-y.pdf

Reference11 articles.

1. Blome C, Augustin M, Klein TM. Nail psoriasis and quality-of-life measurement in clinical trials: call for the use of nail-specific instruments. Am J Clin Dermatol. 2021;22:747–55.

2. Kirkham BW, Egeberg A, Behrens F, et al. A comprehensive review of ixekizumab efficacy in nail psoriasis from clinical trials for moderate-to-severe psoriasis and psoriatic arthritis. Rheumatol Ther. 2023;10:1127–46.

3. Elewski BE, Okun MM, Papp K, et al. Adalimumab for nail psoriasis: efficacy and safety from the first 26 weeks of a phase 3, randomized, placebo-controlled trial. J Am Acad Dermatol. 2018;78:90–9.e1.

4. Egeberg A, Kristensen LE, Puig L, et al. Network meta-analyses comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis at 24–28 and 48–52 weeks. J Dermatol Treat. 2023;34:2263108.

5. Huang IH, Wu PC, Yang TH, et al. Small molecule inhibitors and biologics in treating nail psoriasis: a systematic review and network meta-analysis. J Am Acad Dermatol. 2021;85:135–43.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identifying Predictors of PASI100 Responses up to Month 12 in Patients with Moderate-to-severe Psoriasis Receiving Biologics in the Psoriasis Study of Health Outcomes (PSoHO);Acta Dermato-Venereologica;2024-09-05